FDA advisers back Pfizer-BioNTech coronavirus vaccine for children 5 to 11, saying benefits outweigh risks

More than 10 months after U.S. adults started receiving coronavirus vaccines, the nation's younger children moved significantly closer to getting a shot of protection when advisers to the Food and Drug Administration on Tuesday endorsed the ...

from Google Alert - Business https://ift.tt/2XL7ij0
More than 10 months after U.S. adults started receiving coronavirus vaccines, the nation's younger children moved significantly closer to getting a shot of protection when advisers to the Food and Drug Administration on Tuesday endorsed the ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize